Remove Bacterium Remove Containment Remove Manufacturing
article thumbnail

Intravacc gets NIAID contract for intranasal gonorrhoea vaccine development

Pharmaceutical Technology

The company will create a comprehensive manufacturing process for NGoXIM to generate batches of the vaccine that are Good Manufacturing Practices-compliant. Therapyx will develop and manufacture the IL-12-containing microspheres in the vaccine called GneX12.

article thumbnail

As gonorrhoea threat grows, Intravacc gets $14m for vaccine hunt

pharmaphorum

Some gonorrhoea infections have become untreatable with all seven main antibiotic classes – a situation last encountered in the 1920s before the advent of effective drugs for the bacterium. At the moment most cases are treated with azithromycin, with intravenous ceftriaxone generally reserved as a last-line therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Symvivo’s Oral COVID-19 Vaccine Enters Clinical Trials

XTalks

We are exceptionally pleased to commence dosing of our oral DNA vaccine for COVID-19 as we continue scale-up and manufacturing activities for future clinical development,” Symvivo’s chief medical officer Eric Sievers said in a press release from the company. Related: Red Meat Allergy Test Gets FDA Clearance. “We

article thumbnail

Worst Food Safety Scandals of 2023

XTalks

European regulation identified 14 key allergens, including celery, cereals containing gluten, crustaceans, eggs, fish, lupin, milk, mollusks, mustard, nuts, peanuts, sesame, soybeans and sulfur dioxide. The reasons for these recalls varied, but the most common cause was the omission of priority allergens on labeling.

article thumbnail

Pfizer and International Trachoma Initiative Deliver One Billionth Zithromax® Dose Toward Trachoma Elimination by 2030

Pfizer

Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. An estimated 1.9

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. It contains the antiviral medications nirmatrelvir and ritonavir. every eight weeks for the 90 mg dose, according to the manufacturer. 2022 Revenue: Pfizer reported an annual revenue of $100.33 billion in 2022, a 23.43 billion, a 42.74

Sales 98